AMSBIO, a leading supplier of human cell lines and research tools, is proud to announce its collaboration with WARR Space Labs, a student group from the Technical University of Munich (TUM). The students undertook an exciting project aimed at advancing our understanding of neurodegenerative disorders, particularly Alzheimer’s disease, through spaceborne experiments.

The aim of the ADDONISS (Ageing and Degenerative Diseases of Neurons on the ISS) project is to conduct research on neuronal cell cultures in the microgravity environment of the International Space Station (ISS). AMSBIO’s contribution to this groundbreaking endeavor includes providing the SH-SY5Y/GFP stable cell line and contributing €1000 towards the team’s funding costs while they were conducting research at the NASA laboratories.

Selina Kanamüller, a member of WARR Space Labs student team at TUM, said “The experience of getting to conduct research in NASA laboratories has been unforgettable. Thanks to the help of AMSBIO and our extensive preparations for more than a year, everything went well.”

On the 15th of March, the experiment was successfully taken to the ISS using the SpaceX Falcon 9 launch vehicle. The WARR Space Labs team is currently evaluating the data gathered from the experiment. As the team awaits the results of the ADDONISS project, there is great anticipation for the potential contribution it may bring to Alzheimer’s research and the broader field of neurodegenerative disease research.

AMSBIO is a leading international supplier of ready-to-use human cell lines including receptor, ion channel, cell signaling, phosphodiesterase, and CRE recombinase lines. The company’s cell lines are extensively validated to ensure that they provide you with the best quality products to support your research.

Read an extended length blog about AMSBIO’s cooperation with the ADDONISS project.
 

About AMS Biotechnology

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products, and services for R&D in the medical, nutrition, cosmetics, and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion, and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics. For drug discovery research, AMSBIO offers assays, recombinant proteins, and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognized as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cells and cell therapy applications. This includes GMP cryopreservation technology, and high-quality solutions for viral delivery.

Recent news from AMSBIO